During the past decade, NZOZ Vitamed conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 15 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 10 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NZOZ Vitamed" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "Pfizer" with 8 trials sponsored, "Shire" with 5 trials sponsored, "Takeda" with 4 trials sponsored and "Galapagos NV" with 4 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NZOZ Vitamed" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Cristcot HCA LLC" with 1 trials as a collaborator, "Excelya" with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "Prothena Biosciences Limited" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "NZOZ Vitamed" are "Crohn's Disease" (7 trials), "Ulcerative Colitis" (6 trials), "Alzheimer Disease" (4 trials), "Colitis, Ulcerative" (3 trials) and "Influenza" (3 trials). Many other conditions were trialed in "NZOZ Vitamed" in a lesser frequency.

Most popular intervention types in "NZOZ Vitamed" are "Drug" (33 trials), "Other" (9 trials), "Biological" (6 trials), "Combination Product" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Filgotinib" (4 trials), "Gantenerumab" (4 trials), "Ontamalimab" (4 trials) and "Baloxavir Marboxil" (3 trials). Other intervention names were less common.

The vast majority of trials in "NZOZ Vitamed" are 42 trials for "All" genders.

Currently, there are NaN active trials in "NZOZ Vitamed". undefined are not yet recruiting, 8 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 15 completed trials in NZOZ Vitamed, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in NZOZ Vitamed, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".